[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370757-105":59,"doc-detail-370757-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","detection-of-high-risk-human-papillomavirus-in-bladder-cancer-an-exploratory-study-from-a-uk-based-population","Detection of High-Risk Human Papillomavirus in Bladder Cancer - An Exploratory Study from a UK-Based Population","","Human papillomavirus (HPV) is a prevalent sexually transmitted infection linked to cancer development, yet its high-risk (HR-HPV) role in UK bladder cancer remains unclear. This exploratory UK-based study analysed 55 fresh bladder specimens (4 benign, 51 malignant) using PCR and Sanger sequencing to detect 12 HR-HPV types. HR-HPV DNA appeared in 33% of cancers, with HPV16, HPV35, and HPV52 most frequent. Immunohistochemistry confirmed HPV E7 expression in 81% of HR-HPV DNA-positive cases, while benign samples were HR-HPV-negative.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/detection-of-high-risk-human-papillomavirus-in-bladder-cancer-an-exploratory-study-from-a-uk-based-population/370757/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/detection-of-high-risk-human-papillomavirus-in-bladder-cancer-an-exploratory-study-from-a-uk-based-population/370757.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s main objective?","Question",{"text":112,"@type":113},"To assess whether HR-HPV DNA is present in bladder cancer specimens from a UK-based population and clarify HR-HPV’s possible involvement.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HR-HPV types detected and verified?",{"text":117,"@type":113},"PCR and Sanger sequencing were used to detect 12 HR-HPV types, and immunohistochemistry (IHC) confirmed HPV E7 protein expression in HR-HPV DNA-positive samples.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find regarding HR-HPV in malignant versus benign specimens?",{"text":121,"@type":113},"HR-HPV DNA was detected in 33% of bladder cancer specimens, while none of the benign samples tested positive.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370757,1790218705,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nDetection of High-Risk Human Papillomavirus in Bladder Cancer: An Exploratory Study from a UK-Based Population  \nMohammed Yahya Ahmed 1, Muharrem Okan Cakir 1, Sarbjinder Sandhu 2 and G. Hossein Ashrafi 1, *  \nAcademic Editors: Vanja Kaliterna and Georgia Levidou  \nReceived: 14 April 2025  \nRevised: 20 June 2025  \nAccepted: 24 June 2025  \nPublished: 25 June 2025  \nCitation: Ahmed, M.Y.; Cakir, M.O.; Sandhu, S.; Ashrafi, G.H. Detection of High-Risk Human Papillomavirus in Bladder Cancer: An Exploratory Study from a UK-Based Population. Biomedicines 2025, 13, 1548 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines13071548  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK; [mohammedyahya1987@hotmail.com](mohammedyahya1987@hotmail.com) (M.Y.A.); [m.okan@kingston.ac.uk](m.okan@kingston.ac.uk) (M.O.C.)  \n2 Kingston Hospital-Department of Urology and Surgery, Kingston upon Thames, London KT2 7QB, UK; [sarb.sandhu@nhs.net](sarb.sandhu@nhs.net)  \n* [Correspondence: h.ashrafi@kingston.ac.uk](Correspondence: h.ashrafi@kingston.ac.uk)  \nAbstract  \nBackground/Objectives: Human papillomavirus (HPV) is a prevalent sexually transmitted infection globally and is linked to the development of various cancers. While several international studies have investigated the incidence of high-risk HPV (HR-HPV) in bladder cancers, no such research has been conducted within the UK. Conflicting results in previous studies leave uncertainty regarding the role of HR-HPV in bladder cancer. This study aimed to assess the presence of HR-HPV DNA in bladder cancer specimens from the UK. Methods: A total of 55 fresh bladder specimens, including 4 benign and 51 malignant samples, were analysed using polymerase chain reaction (PCR) and Sanger sequencing to detect 12 HR-HPV types. Immunohistochemistry (IHC) was used to confirm the expression of the HPV E7 protein in HR-HPV-positive samples. Results: HR-HPV DNA was detected in 33% of bladder cancer specimens, with HPV16, HPV35, and HPV52 being the most prevalent types. None of the benign samples tested positive for HR-HPV. IHC confirmed HPV E7 protein expression in 81% of HR-HPV DNA-positive cancer samples. Conclusions: The findings suggest that HR-HPV may play a role in a subset of bladder cancers in the UK. The absence of HR-HPV in benign bladder specimens supports its potential involvement in cancer progression. Further research is needed to clarify the mechanistic role of HR-HPV in bladder cancer development.  \nKeywords: human papillomavirus; HPV; high-risk HPV; bladder cancer; human papillomavirus; PCR; immunohistochemistry; oncoprotein E7  \n1. Introduction  \nBladder cancer is the sixth most common cancer worldwide with over 440,000 newly diagnosed cases annually and 160,000 fatalities [1] . The estimated number of new bladder cancer cases within the UK population alone is 10,200 with 5400 expected deaths annually, a number which unfortunately continues to rise steadily [2] .  \nBladder cancer was the first cancer to be associated with industrialisation due to the increased cancer cases amongst dye workers who worked with aromatic amines. Other risk factors for bladder cancer are known to include old age, cigarette smoking, male gender, arsenic in drinking water, and infection of the bladder [3–5] .  \nInfectious agents, including high-risk Human Papillomaviruses (HR-HPVs), are recognised carcinogens in several cancer types. HPVs are small, non-enveloped viruses that infect epithelial surfaces such as the skin and genital areas through sexual or skin-to-skin  \ncontact, leading to h","cbCaidbQk64ri5ms","https://ap.wps.com/l/cbCaidbQk64ri5ms","pdf",1337098,12,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# 1. Introduction\n## Global and UK burden of bladder cancer\n## Known risk factors for bladder cancer\n## HPV biology and oncogenic mechanisms\n## Prior evidence linking HPV to bladder cancer","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To assess whether HR-HPV DNA is present in bladder cancer specimens from a UK-based population and clarify HR-HPV’s possible involvement.\"},{\"question\":\"How were HR-HPV types detected and verified?\",\"answer\":\"PCR and Sanger sequencing were used to detect 12 HR-HPV types, and immunohistochemistry (IHC) confirmed HPV E7 protein expression in HR-HPV DNA-positive samples.\"},{\"question\":\"What did the study find regarding HR-HPV in malignant versus benign specimens?\",\"answer\":\"HR-HPV DNA was detected in 33% of bladder cancer specimens, while none of the benign samples tested positive.\"}]","Detection of High-Risk Human Papillomavirus in Bladder Cancer - An Exploratory Study from a UK-Based Population | PDF",1790190238,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e143df1debbcae0a58542375e58eff8.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f36c38b0245cba8a8c4b660dd7a162c4.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0803c243b4750872af3b2184f1301fb4.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55606132cb6d494b919d2e9f90656d42.webp",980,1385]